129 related articles for article (PubMed ID: 22154708)
1. Acquired lithium resistance revisited: discontinuation-induced refractoriness versus tolerance.
Post RM
J Affect Disord; 2012 Sep; 140(1):6-13. PubMed ID: 22154708
[TBL] [Abstract][Full Text] [Related]
2. Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study.
Öhlund L; Ott M; Oja S; Bergqvist M; Lundqvist R; Sandlund M; Salander Renberg E; Werneke U
BMC Psychiatry; 2018 Feb; 18(1):37. PubMed ID: 29415689
[TBL] [Abstract][Full Text] [Related]
3. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
Franks M; Macritchie KA; Mahmood T; Young AH
J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence following discontinuation of 28 years of lithium therapy].
Wegmann SD; Kessing LV
Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017
[TBL] [Abstract][Full Text] [Related]
5. Continuation versus discontinuation of lithium during pregnancy: a retrospective case series.
Deiana V; Chillotti C; Manchia M; Carta P; Bocchetta A; Ardau R; Del Zompo M
J Clin Psychopharmacol; 2014 Jun; 34(3):407-10. PubMed ID: 24525653
[No Abstract] [Full Text] [Related]
6. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
7. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
9. [Lithium-associated hyperparathyroidism].
Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Parrilla Paricio P
Med Clin (Barc); 2016 Apr; 146(8):e43-4. PubMed ID: 26654559
[No Abstract] [Full Text] [Related]
10. Lithium-induced thyrotoxicosis in a patient with treatment-resistant bipolar type I affective disorder.
Chalasani S; Benson KA
Med J Aust; 2014 Nov; 201(9):541-2. PubMed ID: 25358581
[No Abstract] [Full Text] [Related]
11. A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient.
Appleby B; Wise T; Isaac A
Harv Rev Psychiatry; 2006; 14(6):330-2. PubMed ID: 17162656
[No Abstract] [Full Text] [Related]
12. Long term treatment of bipolar disorder.
Silverstone T; Romans S
Drugs; 1996 Mar; 51(3):367-82. PubMed ID: 8882376
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
Tondo L; Baldessarini RJ; Floris G
Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
[TBL] [Abstract][Full Text] [Related]
14. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
15. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
[TBL] [Abstract][Full Text] [Related]
16. On being bipolar without being bipolar.
Goldberg J
J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
[No Abstract] [Full Text] [Related]
17. Reversible skin rash in a bipolar disorder patient on first use of lithium.
Wang EH; Yang AC
Psychiatry Clin Neurosci; 2013 Jul; 67(5):365. PubMed ID: 23859668
[No Abstract] [Full Text] [Related]
18. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.
Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A
Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663
[TBL] [Abstract][Full Text] [Related]
19. Evolving trends in the long-term treatment of bipolar disorder.
Vieta E; Rosa AR
World J Biol Psychiatry; 2007; 8(1):4-11. PubMed ID: 17366344
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
